PBMs appeal FTC case over insulin costs 

After a federal judge ruled that the Federal Trade Commission’s case against pharmacy benefit managers could move forward, the PBMs have upped their claim by filing an appeal.

Express Scripts, Caremark, OptumRx and others filed their appeal Friday to the U.S. Court of Appeals for the Eighth Circuit.

Read the full post on News Feed